Inhibition of erbB receptor (HER) tyrosine kinases as a strategy to abrogate antiestrogen resistance in human breast cancer.

Kurokawa H, Arteaga CL
Clin Cancer Res. 2001 7 (12 Suppl): 4436s-4442s; discussion 4411s-4412s

PMID: 11916237

MeSH Terms (13)

Breast Neoplasms Drug Resistance, Neoplasm Enzyme Inhibitors Estrogen Receptor Modulators Female Humans MAP Kinase Signaling System Mitogen-Activated Protein Kinases Receptor, ErbB-2 Receptor Cross-Talk Receptors, Estrogen Signal Transduction Tamoxifen

Connections (1)

This publication is referenced by other Labnodes entities:

Links